2024 |
RenovoRx Inc
|
Independent Director |
- |
- |
2023 |
Quince Therapeutics Inc
|
Lead Independent Director |
98.6 K |
-20.8 % |
2023 |
RenovoRx Inc
|
Independent Director |
82.0 K |
-19.7 % |
2022 |
Quince Therapeutics Inc
|
Lead Independent Director |
124.4 K |
-71.6 % |
2022 |
RenovoRx Inc
|
Independent Director |
102.1 K |
60.2 % |
2021 |
Quince Therapeutics Inc
|
Lead Independent Director |
438.9 K |
16.2 % |
2021 |
RenovoRx Inc
|
Independent Director |
63.7 K |
- |
2020 |
Quince Therapeutics Inc
|
Lead Independent Director |
377.6 K |
-20.2 % |
2020 |
RenovoRx Inc
|
Independent Director |
- |
- |
2019 |
Quince Therapeutics Inc
|
Independent Director |
473.3 K |
- |
2018 |
Quince Therapeutics Inc
|
Independent Director |
- |
- |
2006 |
Celldex Therapeutics Inc.
|
Chief Executive Officer, President and Director |
- |
- |
2005 |
Celldex Therapeutics Inc.
|
Chief Executive Officer, President and Director |
- |
- |
2004 |
Celldex Therapeutics Inc.
|
Chief Executive Officer, President and Director |
- |
- |
2003 |
Celldex Therapeutics Inc.
|
Chief Executive Officer, President and Director |
- |
- |
2002 |
Celldex Therapeutics Inc.
|
Chief Executive Officer, President, Chief Operatin |
- |
- |
2001 |
Celldex Therapeutics Inc.
|
Chief Executive Officer, President, Chief Operatin |
- |
- |
2000 |
Celldex Therapeutics Inc.
|
Chief Executive Officer, President, Chief Operatin |
- |
- |